Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.

Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayr, B., Pötter, E., Goretzki, P., Rüschoff, J., Dietmaier, W., Hoang-Vu, C., Dralle, H., Brabant, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150093/
https://www.ncbi.nlm.nih.gov/pubmed/9528832
Descripción
Sumario:Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants. IMAGES:

Ejemplares similares